PDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation

Journal of Autoimmunity

Volumn 67, Issue , 2016, Pages 8-18

  Duraes, Fernanda V ^a   Lippens, Carla ^a   Steinbach, Karin ^a   Dubrot, Juan ^a   Brighouse, Dale ^a   Bendriss Vermare, Nathalie ^b   Issazadeh Navikas, Shohreh ^c   Merkler, Doron ^a,d   Hugues, Stephanie ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Cell therapy; Central nervous system; Experimental autoimmune encephalomyelitis; Plasmacytoid dendritic cells

Indexed keywords

CHEMERIN; AUTOANTIGEN; CHEMERIN PROTEIN, MOUSE; CHEMOKINE; CMKLR1 PROTEIN, MOUSE; G PROTEIN COUPLED RECEPTOR; SIGNAL PEPTIDE;

ACUTE DISEASE; ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNE DISEASE; CELL FUNCTION; CELL INFILTRATION; CELL MIGRATION; CELL THERAPY; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MACROPHAGE; MICROGLIA; MOUSE; NONHUMAN; PATHOGENICITY; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REMISSION; STEADY STATE; THERAPY EFFECT; UPREGULATION; ANIMAL; BIOLOGICAL THERAPY; CHEMOTAXIS; DENDRITIC CELL; DISEASE MODEL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; MYELIN SHEATH; PATHOLOGY; SPINAL CORD;

ADOPTIVE TRANSFER; ANIMALS; AUTOANTIGENS; CELL- AND TISSUE-BASED THERAPY; CHEMOKINES; CHEMOTAXIS; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, KNOCKOUT; MYELIN SHEATH; RECEPTORS, G-PROTEIN-COUPLED; SPINAL CORD;

EID: 84957436679     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2015.08.014     Document Type: Article

References (43)

1. Soumelis V., Liu Y.J. From plasmacytoid to dendritic cell: morphological and functional switches during plasmacytoid pre-dendritic cell differentiation. Eur. J. Immunol. 2006, 36:2286-2292.
2. Chan V.S., Nie Y.J., Shen N., Yan S., Mok M.Y., Lau C.S. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun. Rev. 2012, 11:890-897.
3. Nestle F.O., Conrad C., Tun-Kyi A., Homey B., Gombert M., Boyman O., Burg G., Liu Y.J., Gilliet M. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J. Exp. Med. 2005, 202:135-143.
4. Pashenkov M., Huang Y.M., Kostulas V., Haglund M., Soderstrom M., Link H. Two subsets of dendritic cells are present in human cerebrospinal fluid. Brain 2001, 124:480-492.
5. Longhini A.L., von Glehn F., Brandao C.O., de Paula R.F., Pradella F., Moraes A.S., Farias A.S., Oliveira E.C., Quispe-Cabanillas J.G., Abreu C.H., et al. Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse. J. Neuroinflammation 2011, 8:2.
6. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003, 3:133-146.
7. Serada S., Fujimoto M., Mihara M., Koike N., Ohsugi Y., Nomura S., Yoshida H., Nishikawa T., Terabe F., Ohkawara T., et al. IL-6 blockade inhibits the induction of myelin antigen-specific Th17 cells and Th1 cells in experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9041-9046.
8. Reder A.T., Feng X. Aberrant Type I interferon regulation in autoimmunity: opposite directions in MS and SLE, shaped by evolution and body ecology. Front. Immunol. 2013, 4:281.
9. Goodkin D.E. Interferon beta treatment for multiple sclerosis: persisting questions. Mult. Scler. 1996, 1:321-324.
10. Teige I., Treschow A., Teige A., Mattsson R., Navikas V., Leanderson T., Holmdahl R., Issazadeh-Navikas S. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis. J. Immunol. 2003, 170:4776-4784.
11. Prinz M., Schmidt H., Mildner A., Knobeloch K.P., Hanisch U.K., Raasch J., Merkler D., Detje C., Gutcher I., Mages J., et al. Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity 2008, 28:675-686.
12. Bailey-Bucktrout S.L., Caulkins S.C., Goings G., Fischer J.A., Dzionek A., Miller S.D. Cutting edge: central nervous system plasmacytoid dendritic cells regulate the severity of relapsing experimental autoimmune encephalomyelitis. J. Immunol. 2008, 180:6457-6461.
13. Isaksson M., Ardesjo B., Ronnblom L., Kampe O., Lassmann H., Eloranta M.L., Lobell A. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE. Eur. J. Immunol. 2009, 39(10):2925-2935.
14. Irla M., Kupfer N., Suter T., Lissilaa R., Benkhoucha M., Skupsky J., Lalive P.H., Fontana A., Reith W., Hugues S. MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J. Exp. Med. 2010, 207:1891-1905.
15. von Glehn F., Santos L.M., Balashov K.E. Plasmacytoid dendritic cells and immunotherapy in multiple sclerosis. Immunotherapy 2012, 4:1053-1061.
16. Kontgen F., Suss G., Stewart C., Steinmetz M., Bluethmann H. Targeted disruption of the MHC class II Aa gene in C57BL/6 mice. Int. Immunol. 1993, 5:957-964.
17. Schaefer B.C., Schaefer M.L., Kappler J.W., Marrack P., Kedl R.M. Observation of antigen-dependent CD8+ T-cell/dendritic cell interactions in vivo. Cell Immunol. 2001, 214:110-122.
18. Muller U., Steinhoff U., Reis L.F., Hemmi S., Pavlovic J., Zinkernagel R.M., Aguet M. Functional role of type I and type II interferons in antiviral defense. Science 1994, 264:1918-1921.
19. Swiecki M., Gilfillan S., Vermi W., Wang Y., Colonna M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity 2010, 33:955-966.
20. Bettelli E., Pagany M., Weiner H.L., Linington C., Sobel R.A., Kuchroo V.K. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 2003, 197:1073-1081.
21. Domingues H.S., Mues M., Lassmann H., Wekerle H., Krishnamoorthy G. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS One 2010, 5:e15531.
22. Guery L., Dubrot J., Lippens C., Brighouse D., Malinge P., Irla M., Pot C., Reith W., Waldburger J.M., Hugues S. Ag-presenting CpG-activated pDCs prime Th17 cells that induce tumor regression. Cancer Res. 2014, 74:6430-6440.
23. Yogev N., Frommer F., Lukas D., Kautz-Neu K., Karram K., Ielo D., von Stebut E., Probst H.C., van den Broek M., Riethmacher D., et al. Dendritic cells ameliorate autoimmunity in the CNS by controlling the homeostasis of PD-1 receptor(+) regulatory T cells. Immunity 2012, 37:264-275.
24. Sawai C.M., Sisirak V., Ghosh H.S., Hou E.Z., Ceribelli M., Staudt L.M., Reizis B. Transcription factor Runx2 controls the development and migration of plasmacytoid dendritic cells. J. Exp. Med. 2013, 210:2151-2159.
25. Swiecki M., Wang Y., Vermi W., Gilfillan S., Schreiber R.D., Colonna M. Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J. Exp. Med. 2011, 208:2367-2374.
26. Sozzani S., Vermi W., Del Prete A., Facchetti F. Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol. 2010, 31:270-277.
27. Zabel B.A., Silverio A.M., Butcher E.C. Chemokine-like receptor 1 expression and chemerin-directed chemotaxis distinguish plasmacytoid from myeloid dendritic cells in human blood. J. Immunol. 2005, 174:244-251.
28. Graham K.L., Zabel B.A., Loghavi S., Zuniga L.A., Ho P.P., Sobel R.A., Butcher E.C. Chemokine-like receptor-1 expression by central nervous system-infiltrating leukocytes and involvement in a model of autoimmune demyelinating disease. J. Immunol. 2009, 183:6717-6723.
29. Graham K.L., Zhang J.V., Lewen S., Burke T.M., Dang T., Zoudilova M., Sobel R.A., Butcher E.C., Zabel B.A. A novel CMKLR1 small molecule antagonist suppresses CNS autoimmune inflammatory disease. PLoS One 2014, 9:e112925.
30. Li H., Zhang G.X., Chen Y., Xu H., Fitzgerald D.C., Zhao Z., Rostami A. CD11c+CD11b+ dendritic cells play an important role in intravenous tolerance and the suppression of experimental autoimmune encephalomyelitis. J. Immunol. 2008, 181:2483-2493.
31. Reizis B., Bunin A., Ghosh H.S., Lewis K.L., Sisirak V. Plasmacytoid dendritic cells: recent progress and open questions. Annu. Rev. Immunol. 2011, 29:163-183.
32. Xiao Y., Jiang Z., Li Y., Ye W., Jia B., Zhang M., Xu Y., Wu D., Lai L., Chen Y., et al. ANGPTL7 regulates the expansion and repopulation of human hematopoietic stem and progenitor cells. Haematologica 2015, 100:585-594.
33. Vermi W., Riboldi E., Wittamer V., Gentili F., Luini W., Marrelli S., Vecchi A., Franssen J.D., Communi D., Massardi L., et al. Role of ChemR23 in directing the migration of myeloid and plasmacytoid dendritic cells to lymphoid organs and inflamed skin. J. Exp. Med. 2005, 201:509-515.
34. Lande R., Gafa V., Serafini B., Giacomini E., Visconti A., Remoli M.E., Severa M., Parmentier M., Ristori G., Salvetti M., et al. Plasmacytoid dendritic cells in multiple sclerosis: intracerebral recruitment and impaired maturation in response to interferon-beta. J. Neuropathol. Exp. Neurol. 2008, 67:388-401.
35. Gao Y., Majchrzak-Kita B., Fish E.N., Gommerman J.L. Dynamic accumulation of plasmacytoid dendritic cells in lymph nodes is regulated by interferon-beta. Blood 2009, 114:2623-2631.
36. Muraro P.A., Robins H., Malhotra S., Howell M., Phippard D., Desmarais C., de Paula Alves Sousa A., Griffith L.M., Lim N., Nash R.A., et al. T cell repertoire following autologous stem cell transplantation for multiple sclerosis. J. Clin. Invest. 2014, 124:1168-1172.
37. Tang Q., Henriksen K.J., Bi M., Finger E.B., Szot G., Ye J., Masteller E.L., McDevitt H., Bonyhadi M., Bluestone J.A. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 2004, 199:1455-1465.
38. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., Nochy D., Debre P., Piette J.C., Gorochov G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 2005, 175:8392-8400.
39. Valencia X., Yarboro C., Illei G., Lipsky P.E. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol. 2007, 178:2579-2588.
40. Van de Keere F., Tonegawa S. CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice. J. Exp. Med. 1998, 188:1875-1882.
41. Olivares-Villagomez D., Wang Y., Lafaille J.J. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med. 1998, 188:1883-1894.
42. Bailey S.L., Schreiner B., McMahon E.J., Miller S.D. CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 2007, 8:172-180.
43. Faunce D.E., Terajewicz A., Stein-Streilein J. Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. 2004, 172:1991-1995.